Size-tunable nanoparticles composed of dextran-b-poly(D,L-lactide) for drug delivery applications

Nano Research

Volumn 5, Issue 1, 2012, Pages 49-61

  Verma, Mohit S ^a   Liu, Shengyan ^a   Chen, Yih Y ^a   Meerasa, Ameena ^a   Gu, Frank X ^a,b  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

biodistribution; controlled drug delivery; Dextran; in vivo; nanoparticles; pharmacokinetics

Indexed keywords

EID: 84855550527     PISSN: 19980124     EISSN: 19980000     Source Type: Journal    
DOI: 10.1007/s12274-011-0184-z     Document Type: Article

References (52)

1. Jain, R. K.; Stylianopoulos, T. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 2010, 7, 653-664.
2. Gu, F. X.; Karnik, R.; Wang, A. Z.; Alexis, F.; Levy-Nissenbaum, E.; Hong, S.; Langer, R. S.; Farokhzad, O. C. Targeted nanoparticles for cancer therapy. Nano Today2007, 2, 14-21.
3. Pridgen, E. M.; Langer, R.; Farokhzad, O. C. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine2007, 2, 669-680.
4. Kim, D. K.; Dobson, J. Nanomedicine for targeted drug delivery. J. Mater. Chem. 2009, 19, 6294-6307.
5. Gref, R.; Minamitake, Y.; Peracchia, M. T.; Trubetskoy, V.; Torchilin, V.; Langer, R. Biodegradable long-circulating polymeric nanospheres. Science1994, 263, 1600-1603.
6. Gaucher, G.; Marchessault, R. H.; Leroux, J. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J. Control. Release2010, 143, 2-12.
7. Dong, Y.; Feng, S. In vitro and in vivo evaluation of methoxy polyethylene glycol-polylactide (MPEG-PLA) nanoparticles for small-molecule drug chemotherapy. Biomaterials2007, 28, 4154-4160.
8. Gursahani, H.; Riggs-Sauthier, J.; Pfeiffer, J.; Lechuga-Ballesteros, D.; Fishburn, C. S. Absorption of polyethylene glycol (PEG) polymers: The effect of PEG size on permeability. J. Pharm. Sci. 2009, 98, 2847-2856.
9. Yang, J.; Cho, E.; Seo, S.; Lee, J.; Yoon, H.; Suh, J.; Huh, Y.; Haam, S. Enhancement of cellular binding efficiency and cytotoxicity using polyethylene glycol base triblock copolymeric nanoparticles for targeted drug delivery. J. Biomed. Mater. Res. A2008, 84A, 273-280.
10. Wei, X.; Gong, C.; Gou, M.; Fu, S.; Guo, Q.; Shi, S.; Luo, F.; Guo, G.; Qiu, L.; Qian, Z. Biodegradable poly(e{open}-caprolactone)-poly(ethylene glycol) copolymers as drug delivery system. Int. J. Pharm. 2009, 381, 1-18.
11. Bazile, D.; Prudhomme, C.; Bassoullet, M. T.; Marlard, M.; Spenlehauer, G.; Veillard, M. Stealth Me. PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm. Sci. 1995, 84, 493-498.
12. Lemarchand, C.; Gref, R.; Couvreur, P. Polysaccharide-decorated nanoparticles. Eur. J. Pharm. Biopharm. 2004, 58, 327-341.
13. Kailasan, A.; Yuan, Q.; Yang, H. Synthesis and characterization of thermoresponsive polyamidoamine-polyethylene glycol-poly(D, L-lactide) core-shell nanoparticles. Acta Biomater. 2010, 6, 1131-1139.
14. Owens, D. E.; Peppas, N. A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 2006, 307, 93-102.
15. Cho, K.; Wang, X.; Nie, S.; Chen, Z.; Shin, D. M. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 2008, 14, 1310-1316.
16. Jiang, W.; Kim, B. Y. S.; Rutka, J. T.; Chan, W. C. W. Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 2008, 3, 145-150.
17. Karnik, R.; Gu, F.; Basto, P.; Cannizzaro, C.; Dean, L.; Kyei-Manu, W.; Langer, R.; Farokhzad, O. C. Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett. 2008, 8, 2906-2912.
18. Goodwin, A. P.; Tabakman, S. M.; Welsher, K.; Sherlock, S. P.; Prencipe, G.; Dai, H. Phospholipid-dextran with a single coupling point: A useful amphiphile for functionalization of nanomaterials. J. Am. Chem. Soc. 2009, 131, 289-296.
19. Nouvel, C.; Frochot, C.; Sadtler, V.; Dubois, P.; Dellacherie, E.; Six, J. Polylactide-grafted dextrans: Synthesis and properties at interfaces and in solution. Macromolecules2004, 37, 4981-4988.
20. Chittasupho, C.; Xie, S.; Baoum, A.; Yakovleva, T.; Siahaan, T. J.; Berkland, C. J. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. Eur. J. Pharm. Sci. 2009, 37, 141-150.
21. Gu, F.; Zhang, L.; Teply, B. A.; Mann, N.; Wang, A.; Radovic-Moreno, A. F.; Langer, R.; Farokhzad, O. C. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 2586-2591.
22. Riley, T.; Govender, T.; Stolnik, S.; Xiong, C. D.; Garnett, M. C.; Illum, L.; Davis, S. S. Colloidal stability and drug incorporation aspects of micellar-like PLA-PEG nanoparticles. Colloids Surf. B-Biointerfaces. 1999, 19, 147-159.
23. Riley, T.; Stolnik, S.; Heald, C. R.; Xiong, C. D.; Garnett, M. C.; Illum, L.; Davis, S. S.; Purkiss, S. C.; Barlow, R. J.; Gellert, P. R. Physicochemical evaluation of nanoparticles assembled from poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) block copolymers as drug delivery vehicles. Langmuir2001, 17, 3168-3174.
24. Zahr, A. S.; Davis, C. A.; Pishko, M. V. Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). Langmuir2006, 22, 8178-8185.
25. Dhar, S.; Gu, F. X.; Langer, R.; Farokhzad, O. C.; Lippard, S. J. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 17356-17361.
26. Shuai, X. T.; Ai, H.; Nasongkla, N.; Kim, S.; Gao, J. M. Micellar carriers based on block copolymers of poly(e{open}-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J. Control. Release2004, 98, 415-426.
27. He, Y. Y.; Zhang, Y.; Gu, C. H.; Dai, W. F.; Lang, M. D. Micellar carrier based on methoxy poly(ethylene glycol)-block-poly(epsilon-caprolactone) block copolymers bearing ketone groups on the polyester block for doxorubicin delivery. J. Mater. Sci.-Mater. Med. 2010, 21, 567-574.
28. Missirlis, D.; Kawamura, R.; Tirelli, N.; Hubbell, J. A. Doxorubicin encapsulation and diffusional release from stable, polymeric, hydrogel nanoparticles. Eur. J. Pharm. Sci. 2006, 29, 120-129.
29. Kataoka, K.; Harada, A.; Nagasaki, Y. Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv. Drug Deliv. Rev. 2001, 47, 113-131.
30. Alpert, A. J. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J. Chromatogr. A1990, 499, 177-196.
31. Drummond, D. C.; Meyer, O.; Hong, K.; Kirpotin, D. B.; Papahadjopoulos, D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 1999, 51, 691-744.
32. 2. Ann. Oncol. 2000, 11, 1029-1033.
33. Magenheim, B.; Levy, M. Y.; Benita, S. A new in vitro technique for the evaluation of drugrelease profile from colloidal carriers-ultrafiltration technique at lowpressure. Int. J. Pharm. 1993, 94, 115-123.
34. Esmaeili, F.; Ghahremani, M. H.; Ostad, S. N.; Atyabi, F.; Seyedabadi, M.; Malekshahi, M. R.; Amini, M.; Dinarvand, R. Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate. J. Drug Target. 2008, 16, 415-423.
35. Dobrovoiskaia, M. A.; Clogston, J. D.; Neun, B. W.; Hall, J. B.; Patri, A. K.; McNeil, S. E. Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett. 2008, 8, 2180-2187.
36. Kim, D.; El-Shall, H.; Dennis, D.; Morey, T. Interaction of PLGA nanoparticles with human blood constituents. Colloid Surf. B-Biointerfaces2005, 40, 83-91.
37. Fischer, D.; Li, Y. X.; Ahlemeyer, B.; Krieglstein, J.; Kissel, T. In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials2003, 24, 1121-1131.
38. Sacco, J. J.; Botten, J.; Macbeth, F.; Bagust, A.; Clark, P. The average body surface area of adult cancer patients in the UK: A multicentre retrospective study. PLoS One2010, 5, e8933-e8933.
39. - T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donors. Blood1997, 89, 2586-2595.
40. Yang, Z.; Leon, J.; Martin, M.; Harder, J. W.; Zhang, R.; Liang, D.; Lu, W.; Tian, M.; Gelovani, J. G.; Qiao, A. et al. Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles. Nanotechnology2009, 20, 165101.
41. Gaucher, G.; Asahina, K.; Wang, J.; Leroux, J. Effect of poly(N-vinyl-pyrrolidone)-block-poly(D, L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles. Biomacromolecules2009, 10, 408-416.
42. Gaur, U.; Sahoo, S. K.; De, T. K.; Ghosh, P. C.; Maitra, A.; Ghosh, P. K. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int. J. Pharm. 2000, 202, 1-10.
43. He, C.; Hu, Y.; Yin, L.; Tang, C.; Yin, C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials2010, 31, 3657-3666.
44. Lee, H.; Fonge, H.; Hoang, B.; Reilly, R. M.; Allen, C. The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. Mol. Pharm. 2010, 7, 1195-1208.
45. Allen, T. M.; Hansen, C. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim. Biophys. Acta-Biomembr. 1991, 1068, 133-141.
46. Rehor, A.; Schmoekel, H.; Tirelli, N.; Hubbell, J. A. Functionalization of polysulfide nanoparticles and their performance as circulating carriers. Biomaterials2008, 29, 1958-1966.
47. Portet, D.; Denizot, B.; Rump, E.; Hindre, F.; Le Jeune, J.; Jallet, P. Comparative biodistribution of thin-coated iron oxide nanoparticles TCION: Effect of different bisphosphonate coatings. Drug Dev. Res. 2001, 54, 173-181.
48. Li, S.; Huang, L. Pharmacokinetics and biodistribution of nanoparticles. Mol. Pharm. 2008, 5, 496-504.
49. Peracchia, M. T.; Fattal, E.; Desmaele, D.; Besnard, M.; Noel, J. P.; Gomis, J. M.; Appel, M.; d'Angelo, J.; Couvreur, P. Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting. J. Control. Release1999, 60, 121-128.
50. Chouly, C.; Pouliquen, D.; Lucet, I.; Jeune, J. J.; Jallet, P. Development of superparamagnetic nanoparticles for MRI: Effect of particle size, charge and surface nature on biodistribution. J. Microencapsul. 1996, 13, 245-255.
51. Passirani, C.; Barratt, G.; Devissaguet, J.; Labarre, D. Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). Pharm. Res. 1998, 15, 1046-1050.
52. Meerasa, A.; Huang, J. G.; Gu, F. X. CH(50): A revisited hemolytic complement consumption assay for evaluation of nanoparticles and blood plasma protein interaction. Curr. Drug Deliv. 2011, 8, 290-298.